Limba
|
PCLX-001 (DDD86481) is an orally active dual N-myristoyltransferase (NMT)inhibitor. It inhibits NMT1and NMT2with IC50 of 5 nM and 8 nM, respectively, in vitro. PCLX-001 inhibits early B-cell receptor (BCR) signalling, which can be used in B-cell malignancy research.
Price | 1.658,00 RON (preturile sunt fara TVA) |
---|---|
Description |
PCLX-001 (DDD86481) is an orally active dual N-myristoyltransferase (NMT)inhibitor. It inhibits NMT1and NMT2with IC50 of 5 nM and 8 nM, respectively, in vitro. PCLX-001 inhibits early B-cell receptor (BCR) signalling, which can be used in B-cell malignancy research. |